P2Y12 Inhibition in Patients with NSTEMI – Can Later Be Better?

Link to article at PubMed

P2Y12 Inhibition in Patients with NSTEMI - Can Later Be Better?

N Engl J Med. 2013 Sep 1;

Authors: Keaney JF

Abstract
Acute coronary syndrome is an umbrella term that is used to describe the abrupt reduction of blood flow to myocardial tissue, typically associated with the rupture of a coronary atherosclerotic plaque. Rupture exposes the blood to plaque contents, resulting in the deposition and activation of platelets and the formation of thrombi. Complete thrombotic occlusion produces ST-segment elevation myocardial infarction, whereas incomplete impairment of coronary blood flow results in unstable angina or, when biomarkers for myocardial injury are present, non-ST-segment elevation myocardial infarction (NSTEMI). Because the rupture of a plaque incites platelet activation and thrombosis, treatments for unstable angina and NSTEMI . . .

PMID: 23991623 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *